Correspondence Re: L.E. Damon et al., Plasma and cerebrospinal fluid pharmacokinetics of 1-beta-D-arabinofuranosylcytosine and 1-beta-D-arabinofuranosyluracil following the repeated intravenous administration of high- and intermediate-dose 1-beta-D-arabinofuranosylcytosine. Cancer Res., 51: 4141-4145, 1991.
Kreis
W
W
Budman
D R
DR
D001086:Arabinofuranosyluracil / Q000493:pharmacokinetics*; D003561:Cytarabine / Q000493:pharmacokinetics*; D003564:Cytidine Deaminase / Q000037:antagonists & inhibitors; D006801:Humans
D003561:Cytarabine; D001086:Arabinofuranosyluracil; D003564:Cytidine Deaminase